1Gaede P, Lund-Andersen H, Parving HH, et al. Effect of a multifactorial intervention on mortality in type 2 diabetes[J]. N Engl J Med,2008,358(6) :580-591.
2Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American heart association and the American diabetes association[J]. Diabetes Care, 2007,30( 1 ) : 162-172.
3Antithrombotic Trialists'(ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randornised trials [J]. Lancet,2009,373(9678):1849-1860.
4Garg JP, Bakris GL. Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease[J]. Vasc Med, 2002,7(1) :35-43.
5Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes[J]. Circulation, 2004 ,110( 1 ) : 32-35.
6Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults[J]. N Engl J Med,2010,362(9) :800-811.
7American diabetes association. Standards of medical care in diabetes-2010[J]. Diabetes Care,2010,33(Suppl) : 1-61.
8Skyler J S, Bergenstal R, Bonow RO, et al. American diabetes association, American college of cardiology foundation, American heart association. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association [J]. Diabetes Care,2009,32(l) :187-192.
9Chobanian AV, Bakris GL, Black HR, et al. National heart, lung, and blood institute joint national vommittee on prevention, fetection, rvaluation, and yreatment of high blood pressure, national high blood ressure education program coordinating committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report[J]. JAMA,2003,289(19) :2560-2572.
10Maneiaa G, Laurentb S, Agabiti-Roseic E, et al. Reappraisal of European guidelines on hypertension management: a European society of hypertension task force document [J].Hypertension, 2009,27(11) :2121-2158.
